GlaxoSmithKline Ventolin HFA inhalers with leak rate issues recalled
GlaxoSmithKline recalls Ventolin HFA inhalers with elevated leak rates. These prescription inhalers (NDC 0173-0682-20) may not deliver medication properly. Affected units have specific lot numbers and expiration dates.
Lower-risk recall
Defective Delivery System: Elevated number of units with out of specification results for leak rate
Contact the company
What happened, in plain English
GlaxoSmithKline is recalling prescription Ventolin HFA inhalers that have a defective delivery system causing elevated leak rates. This means the inhalers may not deliver the correct dose of medication to users. Read more at govinfonow.com/recall/41622-glaxosmithkline-ventolin-hfa-inhalers-with-leak-rate-issues-recalled.
Source Summary by GovInfoNow · govinfonow.com/recall/41622-glaxosmithkline-ventolin-hfa-inhalers-with-leak-rate-issues-recalled · Updated October 8, 2026 · FDA enforcement record: FDA #D-0793-2017
Cite this page
“GlaxoSmithKline Ventolin HFA inhalers with leak rate issues recalled.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41622-glaxosmithkline-ventolin-hfa-inhalers-with-leak-rate-issues-recalled. Based on FDA recall #D-0793-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0793-2017%22&limit=1).
Why it’s dangerous
The inhalers have a leak rate that is outside the acceptable specifications. This means the medication may not be delivered properly to the lungs, potentially reducing effectiveness for treating asthma or other respiratory conditions.
Who’s affected
Prescription inhaler users who have the specific lot numbers listed (7ZP0634, 7ZP0810, 7ZP0990) with expiration date 5/18. Those who use the inhaler for asthma or respiratory conditions are most at risk.
How to tell if you have this one
Check the lot number on the inhaler label: 7ZP0634, 7ZP0810, or 7ZP0990. The expiration date should be May 2018 (5/18). These are prescription-only inhalers with NDC code 0173-0682-20.
- Brand
GlaxoSmithKline- Category
Drug
What to do — step by step
Check Inhaler Details
Look for the lot numbers 7ZP0634, 7ZP0810, or 7ZP0990 and expiration date May 2018 on the inhaler label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the US and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 15 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is there a risk of serious injury from this inhaler?
The recall is for medication delivery issues, not a risk of serious injury. The danger level is low risk as the inhaler may not work properly but does not cause physical harm.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0793-2017 (May 16, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0793-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.